Superselective cisplatin (CDDP)-carboplatin (CBDCA) combined infusion for head and neck cancers

Eur J Radiol. 1995 Dec 15;21(2):94-9. doi: 10.1016/0720-048x(95)00692-j.

Abstract

A group of 26 patients with carcinoma of the head and neck region was treated by superselective intra-arterial infusion of cisplatin (CDDP)-carboplatin (CBDCA). The tumor locations included the tongue (n = 4), oral base (n = 2), nasopharynx (n = 2), oropharynx (n = 8), hypopharynx (n = 4) and larynx (n = 4). Using the coaxial technique, a microcatheter was placed in the lingual, ascending pharyngeal, facial and superior thyroidal arteries according to the location of the tumor. Under imaging studies, CDDP (50 mg/m2)-CBDCA (300 mg/m2) was infused into the vessel, via injectors at the rate of 12.5 ml/min. One to five injections were given every 4 weeks. During and following the chemotherapy the patients received radiotherapy (n = 22), surgery (n = 4) or both (n = 3). Sixty-six sessions of intra-arterial chemotherapy were given with no major complications. Drug-related systemic side effects were mild. The overall response rate was 96% (complete response (CR) 50% and partial response (PR) 46%). Superselective CDDP-CBDCA combined infusion is feasible, relatively non-toxic, and important as multimodality therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Carboplatin / administration & dosage*
  • Carboplatin / adverse effects
  • Carcinoma, Squamous Cell / drug therapy*
  • Carcinoma, Squamous Cell / surgery
  • Catheterization, Peripheral / instrumentation
  • Chemotherapy, Cancer, Regional Perfusion*
  • Cisplatin / administration & dosage*
  • Cisplatin / adverse effects
  • Combined Modality Therapy
  • Feasibility Studies
  • Head and Neck Neoplasms / drug therapy*
  • Head and Neck Neoplasms / surgery
  • Humans
  • Hypopharyngeal Neoplasms / drug therapy
  • Hypopharyngeal Neoplasms / surgery
  • Infusions, Intra-Arterial
  • Laryngeal Neoplasms / drug therapy
  • Laryngeal Neoplasms / surgery
  • Middle Aged
  • Mouth Neoplasms / drug therapy
  • Mouth Neoplasms / surgery
  • Nasopharyngeal Neoplasms / drug therapy
  • Nasopharyngeal Neoplasms / surgery
  • Oropharyngeal Neoplasms / drug therapy
  • Oropharyngeal Neoplasms / surgery
  • Radiotherapy, Adjuvant
  • Remission Induction
  • Tongue Neoplasms / drug therapy
  • Tongue Neoplasms / surgery

Substances

  • Antineoplastic Agents
  • Carboplatin
  • Cisplatin